Skip to main content

Table 1 Patients’ characteristics; Details on patients included in immunohistochemistry (A) and EIA study (B) are shown

From: Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients

Stage Patients (n)
I 34
II 10
III 100
IV 3
n.a. 5
Grade  
G1 37
G2 50
G3 53
n.a. 12
deaths 102
cystic lesions 21
inflammatory diseases 18
benign tumors 34
malignant tumors 38
total 111
  1. n.a. = data on grade/FIGO stage were not available.